PMID- 28285988 OWN - NLM STAT- MEDLINE DCOM- 20180731 LR - 20221207 IS - 1878-0334 (Electronic) IS - 1871-4021 (Linking) VI - 11 Suppl 1 DP - 2017 Nov TI - Essential parameters and risk factors of the patients for diabetes care and treatment. PG - S315-S320 LID - S1871-4021(16)30302-2 [pii] LID - 10.1016/j.dsx.2017.03.008 [doi] AB - AIM: The aim was to explore the association between Type 2 Diabetes Mellitus [T2DM] treatment satisfactions of patients regarding their socio-economic, life-style, history medication and clinical outcome in a Turkish population SUBJECT AND METHODS: A cross-sectional study conducted from February 2016 to September 2016. Of the total 1500 diabetic patients approached, 1094 (72.9%) gave their consent. Data analysis included, sociodemographic, serum lipid profiles (LDL, HDL), calcium, uric acid, blood pressure and glycated hemoglobin (HbA1c) at baseline and after six months. The Diabetes Treatment Satisfaction Questionnaire (DTSQ) tools were used to measure the patient satisfaction. RESULTS: The mean and standard deviation of age among gender, there were significant differences between males (51.81+/-14.40) and females (49.76+/-13.99) (p=0.024). There were statistically significant differences between males and females regarding place of living (city 76% vs town 26%) p<0.001) and consanguinity (p=0.040). Almost of the patients with diabetes were overweight (males 44.5% vs females 41.8%) while more than a quarter (31.2%) males were obese. Among patients with diabetes, significantly larger proportion were treated for DM with insulin (females 28.8% vs males 22.5%) and 'insulin & oral anti diabetic drugs' (females 21.6% vs males 18.4%%; p<0.001) in comparison. Reported average sleeping haours was significantly more among males (6.5+/-1.1 vs. 6.1+/-1.2; p<0.001) than females. Males and females reported significantly greater improvements in mean values of blood glucose (-2.07 p<0.001; vs. -2.36; p=0.007), HbA1c (-1.72 p<0.001; vs. -1.47 p=0.038), potassium (+0.98 p<0.001; vs. +0.93 p<0.005); albumin (-3.38 p<0.001; vs. -3.60; p<0.001); billirubin (-0.69 p=0.049; vs. -0.98; p<0.001); uric acid (+11.9 p=0.017; vs. +14.3; p<0.001); systolic blood pressure (-3.86 p<0.001; vs. -3.2 p<0.001) and diastolic blood pressure (-3.17 p<0.001; vs. -3.2 p<0.001) in comparison to 6 months before. Multivariate stepwise regression analysis showed that the satisfaction DTSQ scores for HbA1c (p<0.001), h of sleep (p<0.001), neuropathy (p=0.007), diabetic education (p=0.014), SBP (mmHg) (p=0.021) DBP (mmHg) (p=0.028) were identified as significantly associated with higher treatment satisfaction. CONCLUSION: The study confirms a positive correlation between diabetes patient's satisfaction with care and treatment. Females DM patients compared to males had a better satisfaction score with current treatment, unacceptably low blood glucose level, flexibility in treatment and understanding of DM. CI - Copyright (c) 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved. FAU - Bener, Abdulbari AU - Bener A AD - Dept. of Biostatistics & Medical Informatics, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey; Dept. of Evidence for Population Health Unit, School of Epidemiology and Health Sciences, The University of Manchester, Manchester, UK; Medipol International School of Medicine, Istanbul Medipol University, Istanbul, Turkey. Electronic address: abdulbari.bener@istanbul.edu.tr. FAU - Keskin, Fatma Ela AU - Keskin FE AD - Division of Endocrinology-Metabolism and Diabetes, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey. FAU - Kurtulus, Eda M AU - Kurtulus EM AD - Dept. of Medical Biochemistry, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey. FAU - Guzel, Mustafa AU - Guzel M AD - Medipol International School of Medicine, Istanbul Medipol University, Istanbul, Turkey. FAU - Cekirdekci, Elif I AU - Cekirdekci EI AD - Dept. of Biostatistics & Medical Informatics, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey; Dept. of Cardiology, Corlu Hospital, MOH, Corlu, Turkey. FAU - Kadioglu, Pinar AU - Kadioglu P AD - Division of Endocrinology-Metabolism and Diabetes, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey. FAU - Konukoglu, Dildar AU - Konukoglu D AD - Dept. of Medical Biochemistry, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey. FAU - Ozturk, Mustafa AU - Ozturk M AD - Medipol International School of Medicine, Istanbul Medipol University, Istanbul, Turkey. LA - eng PT - Journal Article DEP - 20170306 PL - Netherlands TA - Diabetes Metab Syndr JT - Diabetes & metabolic syndrome JID - 101462250 RN - 0 (Blood Glucose) RN - 0 (Glycated Hemoglobin A) RN - 0 (Hypoglycemic Agents) RN - 0 (hemoglobin A1c protein, human) SB - IM MH - Adult MH - Blood Glucose/analysis MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 2/*drug therapy/epidemiology MH - Female MH - Follow-Up Studies MH - Glycated Hemoglobin/analysis MH - Humans MH - Hypoglycemic Agents/*therapeutic use MH - Male MH - Middle Aged MH - Obesity/complications MH - Outcome and Process Assessment, Health Care/*standards MH - *Patient Satisfaction MH - Primary Health Care/*methods MH - *Quality Indicators, Health Care MH - Risk Factors MH - Turkey/epidemiology OTO - NOTNLM OT - DTSQ OT - Diabetes care OT - Health status OT - Life-style OT - Patient satisfaction OT - Treatment adherence EDAT- 2017/03/14 06:00 MHDA- 2018/08/01 06:00 CRDT- 2017/03/14 06:00 PHST- 2016/12/16 00:00 [received] PHST- 2017/03/03 00:00 [accepted] PHST- 2017/03/14 06:00 [pubmed] PHST- 2018/08/01 06:00 [medline] PHST- 2017/03/14 06:00 [entrez] AID - S1871-4021(16)30302-2 [pii] AID - 10.1016/j.dsx.2017.03.008 [doi] PST - ppublish SO - Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S315-S320. doi: 10.1016/j.dsx.2017.03.008. Epub 2017 Mar 6.